ArticleRSC advances2026
Optimization of moving bed biofilm reactor (MBBR) operation for biodegradation of Diuron herbicide and organic load removal from synthetic wastewater.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Filamentous Algae for Wastewater Circularity: A Review of Wastewater Treatment, Resource Recovery, and Biorefinery Opportunities.Microorganisms · 2026Review
- Synergies of Quorum Sensing and Biofilm Dynamics in the Bioremediation of Emerging Medical Organic Pollutants.TheScientificWorldJournal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluates the performance of a laboratory-scale Moving Bed Biofilm Reactor (MBBR) for the biological removal of the herbicide Diuron and simultaneous reduction of chemical oxygen demand (COD) from synthetic wastewater. The reactor was operated under varying hydraulic retention times (HRT = 24, 48, and 72 h), carrier fill fractions (30%, 50%, and 70%), influent COD levels (500-1500 mg L
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.